383 related articles for article (PubMed ID: 27287300)
1. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.
Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG
Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
Jotwani V; Scherzer R; Glidden DV; Mehrotra M; Defechereux P; Liu A; Gandhi M; Bennett M; Coca SG; Parikh CR; Grant RM; Shlipak MG
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):169-174. PubMed ID: 29767638
[TBL] [Abstract][Full Text] [Related]
4. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
[TBL] [Abstract][Full Text] [Related]
5. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
6. Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
Mashingaidze-Mano R; Bwakura-Dangarembizi MF; Maponga CC; Morse GD; Monera-Penduka TG; Mtisi TJ; Mudzviti T; Mujuru HA
PLoS One; 2020; 15(7):e0235759. PubMed ID: 32634168
[TBL] [Abstract][Full Text] [Related]
7. Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women.
Jotwani V; Scherzer R; Abraham A; Estrella MM; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Ix JH; Sarnak MJ; Parikh CR; Shlipak MG
Clin J Am Soc Nephrol; 2015 Jan; 10(1):63-73. PubMed ID: 25370597
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients.
Cheng CY; Chang SY; Lin MH; Ku SY; Sun NL; Cheng SH
J Infect Chemother; 2016 Nov; 22(11):744-747. PubMed ID: 27613487
[TBL] [Abstract][Full Text] [Related]
9. Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
Mugwanya K; Baeten J; Celum C; Donnell D; Nickolas T; Mugo N; Branch A; Tappero J; Kiarie J; Ronald A; Yin M; Wyatt C;
J Infect Dis; 2016 Oct; 214(7):1050-7. PubMed ID: 27029778
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans.
Kim JE; Scherzer R; Estrella MM; Ix JH; Shlipak MG
AIDS; 2016 Apr; 30(7):1049-57. PubMed ID: 26760455
[TBL] [Abstract][Full Text] [Related]
11. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.
Vrouenraets SM; Fux CA; Wit FW; Garcia EF; Furrer H; Brinkman K; Hoek FJ; Abeling NG; Krediet RT; Reiss P;
AIDS; 2011 Nov; 25(17):2149-55. PubMed ID: 21857491
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease.
Mizushima D; Nguyen DTH; Nguyen DT; Matsumoto S; Tanuma J; Gatanaga H; Trung NV; van Kinh N; Oka S
J Infect Chemother; 2018 Jul; 24(7):549-554. PubMed ID: 29602711
[TBL] [Abstract][Full Text] [Related]
13. Urine alpha1-microglobulin is a better marker for early tubular dysfunction than beta2-microglobulin among tenofovir-exposed human immunodeficiency virus-infected men who have sex with men.
Kang J; Liu J; Ding H; Li X; Wang Q; Guo X; Geng W; Shang H
Braz J Infect Dis; 2015; 19(4):410-6. PubMed ID: 26119851
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.
Zhang WR; Scherzer R; Estrella MM; Ascher SB; Muiru A; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Kassaye S; Sharma A; Cohen M; Tien PC; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
AIDS; 2019 Mar; 33(4):723-733. PubMed ID: 30830887
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury.
Samuels R; Bayerri CR; Sayer JA; Price DA; Payne BAI
AIDS; 2017 Jun; 31(9):1297-1301. PubMed ID: 28323756
[TBL] [Abstract][Full Text] [Related]
16. Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
Casado JL; Del Rey JM; Bañón S; Santiuste C; Rodriguez M; Moreno A; Perez-Elías MJ; Liaño F; Moreno S
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):416-22. PubMed ID: 26962850
[TBL] [Abstract][Full Text] [Related]
17. Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya.
Karoney MJ; Koech MK; Njiru EW; Owino Ong'or WD
PLoS One; 2022; 17(9):e0273183. PubMed ID: 36108078
[TBL] [Abstract][Full Text] [Related]
18. Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation.
Ascher SB; Scherzer R; Estrella MM; Zhang WR; Muiru AN; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Young M; Sharma A; Cohen MH; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
Clin J Am Soc Nephrol; 2018 Sep; 13(9):1321-1329. PubMed ID: 30154221
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.
Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM
Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
